Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
      Biotech

      Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension

      March 18, 2025
      iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
      Biotech

      iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair

      March 17, 2025
      iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors
      Biotech

      iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors

      March 17, 2025
      iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors
      Biotech

      iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors

      March 15, 2025
      WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY
      Biotech

      WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY

      March 15, 2025
      INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
      Biotech

      INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

      March 14, 2025
      New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence
      Biotech

      New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence

      March 14, 2025
      Accropeutics Secured $12 Million in Series B Plus Financing
      Biotech

      Accropeutics Secured $12 Million in Series B Plus Financing

      March 14, 2025
      WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
      Biotech

      WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025

      March 13, 2025
      Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older
      Biotech

      Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

      March 13, 2025
      « 1 … 42 43 44 45 46 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026